Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Detalles Bibliográficos
Autores principales: Chabon, Jacob J., Simmons, Andrew D., Lovejoy, Alexander F., Esfahani, Mohammad S., Newman, Aaron M., Haringsma, Henry J., Kurtz, David M., Stehr, Henning, Scherer, Florian, Karlovich, Chris A., Harding, Thomas C., Durkin, Kathleen A., Otterson, Gregory A., Thomas Purcell, W., Ross Camidge, D., Goldman, Jonathan W., Sequist, Lecia V., Piotrowska, Zofia, Wakelee, Heather A., Neal, Joel W., Alizadeh, Ash A., Diehn, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114547/
https://www.ncbi.nlm.nih.gov/pubmed/27841271
http://dx.doi.org/10.1038/ncomms13513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114547/
https://www.ncbi.nlm.nih.gov/pubmed/27841271
http://dx.doi.org/10.1038/ncomms13513

Ejemplares similares